21 22 Research article 23 Running head: Non-motor and genetic features of PD to classify Lewy body diseases 24 Word count: Abstract: 244; Text: 3166; References: 39; Tables: 3; Figures: 1. 25 2 1 ABSTRACT 2 Introduction: The use of non-motor Parkinson's disease (PD) features and genetic PD 3 variants for clustering analyses may refine the phenotypic classification of idiopathic 4 Lewy body (LB) diseases. 5 Methods: One-hundred participants [n=7 E46K-SNCA (n=5 symptomatic and n=2 6 asymptomatic), n=4 PARK2, n=3 LRRK2, n=8 dementia with Lewy bodies (DLB), n=48 7 idiopathic PD (iPD), n=30 healthy controls (HC)] underwent a comprehensive evaluation 8 of non-motor and motor PD features. Non-motor features were used to perform a 9 hierarchical clustering analysis with patients and HC using a Scikit-learn toolkit.
1 Keywords: Lewy bodies, Parkinson's disease, cognition, genetic, clustering analysis 1 hierarchical clustering analysis, which was performed including all study subjects, both 2 patients and HC. Features exclusively related to the disease were not included in the 3 analysis and were used post-hoc to compare patients within clusters.
4
The hierarchical clustering analysis is based on a bottom up approach. Complete 5 linkage criterion was used minimizing the maximum distance between observations of 6 pairs of clusters. k = 3 was selected to offer a good combination of model fit and 7 parsimony. For each identified cluster, we obtained the average (centroid) z score of each 8 variable included to perform hierarchical clustering analysis. All analyses were 9 performed with Scikit-Learning [32] running under Python version 3.6.5. The general characteristics of study participants are displayed in Table 1 . In 24 general terms, they were predominantly male (62.0%) and young (57.4 years). DLB 25 patients were older than the other groups, with statistically significant (p<0.05) 1 differences compared to E46K-SNCA carriers, PARK2, iPD and HC. iPD patients were 2 also older than genetic carriers and HC, although differences were statistically significant 3 only when compared to HC. Regarding overall cognitive status (MoCA), both DLB and 4 E46K-SNCA symptomatic carriers were the most affected, and there were not significant 5 differences between them. However, DLB patients showed significant lower cognitive 6 scores compared to E46K-SNCA asymptomatic carriers, iPD patients, PARK2 carriers 7 and HC. In addition, HC showed higher cognitive scores compared to E46K-SNCA The hierarchical clustering analysis distributed study participants in three clusters:
17 cluster 1 "normal-to-mild" (N=45), cluster 2 "mild-to-moderate" (N=23) and cluster 3 18 "severe" (N=32). Table 2 shows the distribution of participants in the three clusters 19 according to their diagnostic category and it also presents cluster differences for all 20 variables included in the clustering. Table 3 shows cluster differences in other relevant 21 variables and PD features not used for hierarchical clustering, which in fact were 22 statistically significant for most comparisons, even after excluding HC. 3 Results are presented as means (standard deviations) unless otherwise specified. Pairwise 4 cluster comparisons were performed using with post-hoc χ2 tests or Tukey's range test, 5 respectively. Statistically significant (p<0.05) results for pairwise cluster comparisons 6 with χ2 (proportions) or one-way ANOVA (means) are represented as: "a" cluster 3 7 versus cluster 2; "b" cluster 3 vs cluster 1; "c" cluster 2 vs cluster 1; "d" tendency for 8 statistical significance (p=0.063) for cluster 2 vs cluster 1. Abbreviations: E46K-SNCA: 9 E46K mutation in alpha-synuclein gene; "E46K-SNCA asymptomatic": asymptomatic 
25
In Figure 1 (Fig. 1-B) . Interestingly, when cluster 3 was compared 3 with cluster 1 and with cluster 2, we observed a peculiar pattern revealing marked 4 differences in neuropsychological tests (visual attention, perception, processing speed 5 and memory and executive functions), that was not present when differences between 6 cluster 1 and cluster 2 were evaluated. 
Motor symptoms and PD-related features
1 Regarding PD-related features, patients in cluster 1 presented earlier disease onset 2 as compared to those in other clusters. Although patients in cluster 3 had longer disease 3 duration as compared to participants in other clusters, the cluster differences for this 4 variable were not statistically significant. Thus, we did not include disease duration as a 5 covariate in subsequent analyses. The severity of motor PD manifestations was markedly 6 higher in patients from cluster 3 as compared to those from clusters 1 and 2 (p<0.05), 7 while it was comparable between cluster 1 and cluster 2. Although there was a progressive 8 increase of LEDD as motor manifestations increased from cluster 1 to cluster 3, cluster 9 differences in LEDD were not statistically significant. Interestingly, axial motor 10 manifestations were significantly more severe for patients in cluster 3 as compared to 11 cluster 1 and cluster 2. 9
Until now, few publications have used clustering analyses to identify PD subtypes 10 based on non-motor symptoms [3, [33] [34] [35] . In such studies, three or four subtypes of PD 11 patients were usually identified, including the phenotypes "old age onset and rapid 12 disease progression" and "young age onset and slow disease progression", which may 13 correspond respectively to the PD phenotypes identified in the present work as cluster 3 25 Moreover, since statistically significant cluster differences persisted even after removing 1 the effect of chronological age on cognitive performance, we cannot completely rule out 2 the effect of age in our analyses, which is in fact a determinant feature conditioning 3 neurodegeneration in PD. Finally, our results are based on cross-sectional data.
4 Therefore, further longitudinal studies are required to investigate whether members of 5 different clusters reveal various course of progression or outcome over time.
6
In conclusion, our clustering analysis, based on an extensive set of non-motor 7 features and including HC, iPD, DLB and three pathophysiological and clinically distinct 8 genetic PD variants differentiated three clusters of profiles in LB diseases. First, "Normal-9 to-mild" cluster with young iPD patients, most HC and the lowest LB burden genetic PD 10 variants (PARK2 and LR RK2) characterized by having normal-to-mild cognitive 11 disabilities and mild-to-moderate motor disability with few axial symptoms; "Mild-to-12 moderate" cluster with old iPD patients classified together with the lowest symptomatic 13 E46K-SNCA carrier and with HCs, characterizing by having mild-to-moderate cognitive 14 and motor disabilities with few axial symptoms; and "Severe" cluster with old iPD 15 classified together with all DLB and the most symptomatic E46K-SNCA carriers, 16 characterized by having severe pattern-specific cognitive disabilities (visual attention, 17 perception, processing speed, memory and executive functions) and severe motor PD 18 manifestations with marked axial symptoms. Hence, our study with genetic PD patients 19 supports the potential value of quantifying non-motor PD features in the clinical setting, 20 particularly visual cognition abnormalities, to help in the identification of those iPD 21 patients at higher risk of developing an aggressive diffuse LB diseases.
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